FI20086024A0 - Uusi farmaseuttinen tuote - Google Patents
Uusi farmaseuttinen tuoteInfo
- Publication number
- FI20086024A0 FI20086024A0 FI20086024A FI20086024A FI20086024A0 FI 20086024 A0 FI20086024 A0 FI 20086024A0 FI 20086024 A FI20086024 A FI 20086024A FI 20086024 A FI20086024 A FI 20086024A FI 20086024 A0 FI20086024 A0 FI 20086024A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical product
- new pharmaceutical
- new
- product
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
- C12Y114/11004—Procollagen-lysine 5-dioxygenase (1.14.11.4), i.e. lysine-hydroxylase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20086024A FI20086024A0 (fi) | 2008-10-29 | 2008-10-29 | Uusi farmaseuttinen tuote |
PCT/FI2009/050869 WO2010049590A2 (en) | 2008-10-29 | 2009-10-29 | A new pharmaceutical product |
EP09759744A EP2349326A2 (en) | 2008-10-29 | 2009-10-29 | A new pharmaceutical product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20086024A FI20086024A0 (fi) | 2008-10-29 | 2008-10-29 | Uusi farmaseuttinen tuote |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20086024A0 true FI20086024A0 (fi) | 2008-10-29 |
Family
ID=39924662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20086024A FI20086024A0 (fi) | 2008-10-29 | 2008-10-29 | Uusi farmaseuttinen tuote |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2349326A2 (fi) |
FI (1) | FI20086024A0 (fi) |
WO (1) | WO2010049590A2 (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140073575A1 (en) * | 2011-04-15 | 2014-03-13 | Universitaet Zuerich Prorektorat Mnw | Collagen hydroxylases |
GB201202561D0 (en) * | 2012-02-15 | 2012-03-28 | Univ Dundee | Treatment of skin disorders |
US20240209029A1 (en) * | 2021-04-21 | 2024-06-27 | The University Of Hong Kong | Adiponectin glycopeptides and compositions and methods of use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034556B2 (en) * | 2004-05-28 | 2011-10-11 | The Regents Of The University Of California | Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity |
WO2007146171A2 (en) * | 2006-06-08 | 2007-12-21 | Trustees Of Tufts College | Purified high molecular weight adiponectin and uses thereof |
WO2009080898A2 (en) * | 2007-12-21 | 2009-07-02 | Oulun Yliopisto | Products and methods for preventing tumour growth |
-
2008
- 2008-10-29 FI FI20086024A patent/FI20086024A0/fi not_active Application Discontinuation
-
2009
- 2009-10-29 WO PCT/FI2009/050869 patent/WO2010049590A2/en active Application Filing
- 2009-10-29 EP EP09759744A patent/EP2349326A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2010049590A3 (en) | 2010-06-24 |
WO2010049590A2 (en) | 2010-05-06 |
EP2349326A2 (en) | 2011-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018030I2 (el) | Φαρμακοτεχνικη μορφη 514 | |
SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
BRPI0920521A2 (pt) | combinação farmacêutica | |
BRPI0908130A2 (pt) | Produto | |
DK2151438T3 (da) | Lægemiddel indeholdende PPAR-Deltaagonist | |
BRPI0813753A2 (pt) | Produto pré-impregnado | |
FI20085052A0 (fi) | Tupakkatuote | |
DK3097925T3 (da) | Farmaceutisk sammensætning | |
ATE531278T1 (de) | Süsswaren-produkt | |
BRPI1004940A2 (pt) | composição farmacêutica | |
SMT201400069B (it) | Formulazione farmaceutica | |
BRPI1015939A2 (pt) | composição farmacêutica | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI1016190A2 (pt) | compostos farmacêuticos. | |
FI20085767L (fi) | Kipsituote | |
BRPI0921654A2 (pt) | formulação farmacêutica | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
DK2271618T3 (da) | Farmaceutiske forbindelser | |
BR112012003149A2 (pt) | composição farmacêutica | |
BRPI0912171A2 (pt) | composição farmacêutica | |
FI20080348A0 (fi) | Uudenlainen farmaseuttinen formulaatio | |
BRPI0921301A2 (pt) | composição farmacêutica | |
FI20086024A0 (fi) | Uusi farmaseuttinen tuote | |
BRPI0920277A2 (pt) | produto | |
BRPI1008983A2 (pt) | formulação farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |